AFT Pharmaceuticals Statistics

Total Valuation

AFT Pharmaceuticals has a market cap or net worth of AUD 275.23 million. The enterprise value is 295.75 million.

Market Cap	275.23M
Enterprise Value	295.75M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+56.43%
Shares Change (QoQ)	-8.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.16M

Valuation Ratios

The trailing PE ratio is 25.83.

PE Ratio	25.83
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	10.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.81, with an EV/FCF ratio of 12.61.

EV / Earnings	27.76
EV / Sales	1.65
EV / EBITDA	15.81
EV / EBIT	17.04
EV / FCF	12.61

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.40.

Current Ratio	2.72
Quick Ratio	1.21
Debt / Equity	0.40
Debt / EBITDA	1.63
Debt / FCF	1.32
Interest Coverage	5.94

Financial Efficiency

Return on equity (ROE) is 14.40% and return on invested capital (ROIC) is 10.33%.

Return on Equity (ROE)	14.40%
Return on Assets (ROA)	7.82%
Return on Capital (ROIC)	10.33%
Revenue Per Employee	1.66M
Profits Per Employee	96,855
Employee Count	110
Asset Turnover	1.29
Inventory Turnover	2.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.54%
50-Day Moving Average	2.55
200-Day Moving Average	2.86
Relative Strength Index (RSI)	49.61
Average Volume (20 Days)	1,781

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AFT Pharmaceuticals had revenue of AUD 182.21 million and earned 10.65 million in profits. Earnings per share was 0.09.

Revenue	182.21M
Gross Profit	81.27M
Operating Income	17.61M
Pretax Income	15.80M
Net Income	10.65M
EBITDA	18.19M
EBIT	17.61M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 9.81 million in cash and 30.88 million in debt, giving a net cash position of -21.07 million.

Cash & Cash Equivalents	9.81M
Total Debt	30.88M
Net Cash	-21.07M
Net Cash Per Share	n/a
Equity (Book Value)	76.67M
Book Value Per Share	0.73
Working Capital	50.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.63 million and capital expenditures -174,401, giving a free cash flow of 23.46 million.

Operating Cash Flow	23.63M
Capital Expenditures	-174,401
Free Cash Flow	23.46M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 44.60%, with operating and profit margins of 9.66% and 5.85%.

Gross Margin	44.60%
Operating Margin	9.66%
Pretax Margin	8.67%
Profit Margin	5.85%
EBITDA Margin	9.98%
EBIT Margin	9.66%
FCF Margin	12.87%

Dividends & Yields

AFT Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	14.46%
Buyback Yield	-56.43%
Shareholder Yield	-56.43%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AFT Pharmaceuticals has an Altman Z-Score of 5.44.

Altman Z-Score	5.44
Piotroski F-Score	n/a